1. Executive Summary 1,486 1,454 1,400 1,312 1,1521,169 1,200 1,083 1,089 972 No

Total Page:16

File Type:pdf, Size:1020Kb

1. Executive Summary 1,486 1,454 1,400 1,312 1,1521,169 1,200 1,083 1,089 972 No Executive Summary - Sample Pages The 2015 Preqin Private Equity Compensation and Employment Review Fig. 1.1: Annual Private Equity Fundraising, 2000 - November 2014 1,600 1. Executive Summary 1,486 1,454 1,400 1,312 1,1521,169 1,200 1,083 1,089 972 No. of Funds Private Equity Fundraising on Track some improvement, particularly recently, 1,000 959 862 852 Closed fundraising levels are still not growing at 816 800 706 685 Private equity fundraising has gained the rate they grew pre-2008, and therefore 630 667 600 556 543 526 Aggregate momentum in recent years, with increasing it is unsurprising that the number of active 428 Capital Raised 362 389 amounts of capital raised each year since private equity fi rms has experienced a 400 318 296 342 ($bn) 238 2010. As of early November 2014, funds similar pattern, with the annual growth in 173 218 200 137 106 closed in 2014 had raised $428bn, $60bn the number of active fi rms tapering in recent more than in the equivalent period in 2013, years. A mix of factors have led to this: 180 0 though this was secured by 96 fewer funds fi rms are deemed to have become inactive than in 2013 (Fig. 1.1). As this suggests, in 2014 (meaning they have not raised a 2000 2001 2002 2003 2004 2005 2006 2007 2008 2009 2010 2011 2012 2013 2014 average fund sizes have increased. In fact, fund in the past 10 years) and 2014 saw the Jan-Nov capital raised in 2014 YTD has already lowest number of new private equity fi rms Year of Final Close exceeded the amount raised in 2012 launch in any year since 1998. ($389bn) but this was across 336 fewer Fig. 1.2: Number of Active Private Equity Firms over Time (By Vintage of First Fund Raised) funds. The $428bn raised so far in 2014 is The 2014 data only includes fi rms that just 19% behind the $526bn raised across have reached a fi nal close or at least one the whole of 2013, and with two months left interim close on their debut funds in order 6,000 of the year and with signifi cant numbers of to begin making investments. It is possible funds expected to close in this time, 2014 that uncertain economic conditions, in 5,000 looks set to be another strong year for conjunction with the challenges faced by private equity fundraising. fi rst-time fund managers in the private 4,000 equity fundraising market, may be New Number of Active Private Equity Firms impacting the number of new private equity 3,000 fi rms choosing to bring vehicles to market. Existing Fig. 1.2 shows the continuous growth in Preqin has previously noted the increased 2,000 the number of active private equity fi rms disparity between the amount of capital No. of Active Firms over time. The pace of this growth has secured by those larger, more established 1,000 declined; this can be tied to the diffi culty managers and those that are raising debut in raising capital for private equity funds in private equity funds. The majority of capital 0 the wake of the global fi nancial crisis. While raised for private equity funds has always fundraising has, as we have seen, shown been accounted for by the larger fi rms, but 1980 1981 1982 1983 1984 1985 1986 1987 1988 1989 1990 1991 1992 1993 1994 1995 1996 1997 1998 1999 2000 2001 2002 2003 2004 2005 2006 2007 2008 2009 2010 2011 2012 2013 2014 Vintage Year © 2014 Preqin Ltd. 1 Executive Summary - Sample Pages the industry has seen the gap widen and do not raise or have not yet raised distinct Fig. 1.3: Average Number of Staff by Firm Assets under Management the proportion represented by fi rst-time private equity funds (i.e. those that manage fund managers has declined signifi cantly. corporate or personal capital and those 140 133 that manage third-party capital without 118 120 Chapter 3 of the 2015 Preqin Private Equity pooling into commingled private investment 105 Compensation and Employment Review vehicles) are included, the total number of 100 Average No. of Employees takes a closer look at how these trends active fi rms under consideration increases 80 differ by fund type and by geographic to 9,000. In total, these fi rms employ an 66 60 54 location. For example, some strategies, estimated 125,000 people, with buyout, Average No. of such as growth and distressed private venture capital and real estate fi rms 37 Employees per 40 28 equity, have seen a greater increase in the representing an estimated 67% of the total 23 25 $1bn AUM 20 16 15 number of active fi rms than has been seen employment of the private equity industry. 6 among other strategies. 0 Preqin’s analysis of employment in the Employment Levels at Private Equity private equity industry, discussed in $10bn or More $250mn Firms $5-9.9bn Chapter 4, shows the positive correlation $1-4.9bn Less than between the number of staff employed by $250-499mn $500-999mn There are currently almost 6,000 fi rms a fi rm and its assets under management. Firm Assets under Management actively managing private equity funds Fig. 1.3 shows that fi rms with the largest worldwide. When private equity fi rms that assets under management (AUM) of $10bn Fig. 1.4: Breakdown of Average Firm-Wide Changes in Base Salaries of Participating Firms Fig. 1.5: Proportion of Participating Firms Reporting an Increase, Decrease or No Change in between 2013 and 2014 Bonus Payouts for Performance in Calendar/Fiscal Year 2013 Compared to Previous Year 60% 55% 50% 11% 26% 40% Increase in Bonus Payouts 30% 30% No Change in Bonus Payouts 20% Decrease in Bonus Payouts 10% 7% Proportion of Participating Firms 4% 3% 2% 63% 0% Decrease No Change 1-10% 11-20% 21-50% More than Increase Increase Increase 50% Increase © 2014 Preqin Ltd. 2 Executive Summary - Sample Pages or more have an average of 118 staff. This $1bn or more that is double the median base Fig. 1.6: Breakdown of When Participating Firms Make Promote/Carried Interest Award equates to an average of six employees per salary of an individual in the same position Payments by Investment Strategy $1bn of AUM. The staff costs are covered at a fi rm with assets under management 100% 0% 3% 5% 10% 7% 11% 5% by the income received from charging of $150mn. Similarly, a managing general 90% 9% 22% Other 5% management fees to their investors, which partner in a fi rm headquartered in the US 80% 45% 22% 32% At the end of the life of 30% 45% are usually based on a percentage of makes on average $84,000 more a year 70% 22% 47% the fund 60% 15% 5% investor commitments. than the same position in Europe. 10% Annually (e.g., at the 50% 9% 11% end of the year) Firms 10% 40% 81% 7% As in previous years, funds with smaller Chapter 7 of the Review lists detailed 30% 59% At the sale of the AUM have a much higher average number benchmark compensation fi gures 50% 52% 20% 45% 44% 40% 40% investment when the of staff per $1bn of their AUM, despite for different positions at participating 10% promote/carried interest having lower average numbers of staff. fi rms. The tables in this chapter include Proportion of Participating 0% is generated Preqin’s latest data shows fi rms with AUM fi gures for base salary, total annual cash of less than $250mn have 16 employees compensation, long-term incentive/carried Other on average, but have an average of around interest awarded and total remuneration Buyout 130 staff members per $1bn of their AUM, data for 60 different positions, including all Mezzanine Real Estate Distressed Infrastructure Private Equity a much higher fi gure than the average for levels of seniority for deal-making positions, Fund of Funds funds with AUM of $10bn or more. Smaller as well as senior executive, administrative/ Venture Capital sized fi rms may have fewer employees, but corporate positions, and positions specifi c with their management fees charged on to real estate management, including smaller amounts of investor commitments asset and portfolio management and small proportion (2%) of participating pool in calendar/fi scal year 2013 compared compared to the larger private equity fi rms, transactions. Where possible, in addition fi rms reported a decrease in base salaries to 2012. the operating economics of the largest to the aggregate fi gures, the information is between 2013 and 2014, while a substantial funds, with higher income from management broken out by assets under management, 30% reported no change. The largest It is evident that compensation practices fees, are often more favourable for their geographic market, and the strategy proportion of participating fi rms (55%) vary by the location or size of a fund. managers. employed (buyout, venture capital, reported an increase in base salaries that Fig. 1.6 details the methods employed infrastructure etc.). Figures are provided for ranged between 1% and 10%. by participating fi rms focused on different Compensation on an Individual Level the 25th percentile, median, average and strategies to make promote/carried interest 75th percentile benchmarks in each case. The majority (63%) of participating fi rms award payments. Exactly half of the fi rms The operating economics, which vary also largely reported no change in their that operate a distressed & special situations by a fi rm’s assets under management or Compensation on a Firm Level bonus pool size in the calendar/fi scal year strategy make award payments at the geography, also impact the remuneration 2013 compared to 2012 (Fig.
Recommended publications
  • Philadelphia Investment Trends Report
    Venture impact Technology investment in the Greater Philadelphia region Trends and highlights, January 2008 to June 2013 Innovation, investment and opportunity On behalf of EY, Ben Franklin Technology Partners of Southeastern Pennsylvania and the Greater Philadelphia Alliance for Capital and Technologies (PACT), we are pleased to present this review 421 companies of technology investment trends and highlights in the Greater Philadelphia region. $4.1 billion The technology investment community in the Greater Philadelphia region includes a wide variety of funding sources supporting a diverse array of companies and industry sectors. In this report, Total investment since we’ve analyzed more than a thousand investment rounds and January 2008 exits that occurred in the Philadelphia region since 2008 – including investments from venture capital fi rms (VCs), angel investors (Angels), corporate/strategic investors, seed funds, accelerators and other sources of funding. As shown in this report, 2012 reversed a post-recession slowdown in venture funding in Greater Philadelphia, and to date, 2013 has brought a welcome increase in the amount of new funds available at regional investment fi rms. These are positive signs for our region’s technology companies, as are the increasing number of exits via IPO and acquisition, which serve as further validation of the investment opportunities created by our region’s growing technology sector. We encourage you to explore this report, and we hope that it will provide useful insights into the current state of
    [Show full text]
  • Overview of Cleveland's Health Care Industry and Bioenterprise Initiative
    Overview of Cleveland’s Health Care Industry and BioEnterprise Initiative November 14, 2007 1 Overview • Regional Health Care Base: 2002 • Transformation: Role of State • BioEnterprise and Entrepreneurship • Lessons Learned 2 Cleveland Health Care Base Nationally-recognized leaders in clinical care and research … • > $450 Million in annual research • Numerous nationally-distinctive programs including: • Cardiovascular • Cancer • Neurology • Orthopedics • Surgery • Pediatrics • Medical imaging • Biomedical engineering • Stem cells & tissue engineering • Advanced materials • Molecular diagnostics • Anti-infectives • Prions • Destination for innovation and care 3 Cleveland Health Care Base … a broad industry base… • ~500 health care Biopharma- companies in region ceutical 16% • Five >$1 billion companies Device/ or divisions Equipment Other 68% • Over 20,000 employees 6% Health Care Services/IT 10% 4 Weak Commercialization …However, few companies were attracting growth equity CLEVELAND AREA CLEVELAND AREA HEALTH CARE VENTURE INVESTMENT HEALTH CARE VENTURE INVESTMENT $ Millions Companies Financed 6 33 5 8 2 01 02 0 0 0 001 2 2 2 20 5 Source: Dow Jones Venture Wire; Venture Source; BioEnterprise Broad Effort Required • Community- People wide effort Pipeline • Collaboration Growth Clinical • Connectedness … regionally Capital and nationally 6 2002: Commitment to Growth • Private • Renewed focus on entrepreneurs and innovation • Technology transfer culture capabilities significantly enhanced • Investment firms and professional services • Public
    [Show full text]
  • Clarity on Mergers and Acquisitions
    Clarity on Mergers & Acquisitions Swiss deal flows hit record high January 2019 16 2018 activity and 2019 outlook An industry-by-industry look at last year’s deals and what you might expect over the next 12 months. 22 Private Equity and the Swiss economy SECA’s General Secretary shares his insights into how Private Equity makes the Swiss economy stronger. 76 Detailed 2018 transaction list View the M&A deals that involved a Swiss buyer, seller or target. 28 4 12 6 18 10 Clarity on Mergers & Acquisitions CONTENT Clarity on Mergers & Acquisitions EDITORIAL CHAPTER II 3 Switzerland’s M&A activity 34 Industry Sector Pages sets a new record 36 Chemicals 40 Commodities CHAPTER I 44 Consumer Markets Overview 48 Financial Services 52 Industrial Markets 12 Media headlines 56 Pharmaceuticals & Life Sciences 60 Power & Utilities 14 Summary 64 Private Equity 68 Real Estate 72 Technology, Media & Telecommunications Focus Topic: Private Equity CHAPTER III 22 What is it and how does it work? 76 List of Swiss M&A 26 The changing legal and regulatory framework for Private Equity in Switzerland transactions in 2018 30 Interview with Maurice Pedergnana, SECA: CHAPTER IV The national economy is healthier thanks to private equity 110 Tombstones 116 PINBOARD 117 CONTACT & IMPRINT 1 2 Clarity on Mergers & Acquisitions EDITORIAL Switzerland’s M&A activity sets a new record activity. In fact, acquisitions by Private Equity houses once more exceeded exits, in a further sign of the growing importance of this community on the M&A landscape. A considerable amount of the M&A activity observed last year is due to changing consumer behaviors and rapid advances in technology – not least i4.0, the ’fourth industrial revolution’ that is upon us thanks to developments in artificial intelligence.
    [Show full text]
  • HEALTHCARE INDUSTRY ASSOCIATION (HCIA) RESUME BOOK Columbia Healthcare and Pharmaceutical Management Program
    HEALTHCARE INDUSTRY ASSOCIATION (HCIA) RESUME BOOK Columbia Healthcare and Pharmaceutical Management Program CLASS OF 2017 CLASS OF 2018 CONTENTS 2017 RESUMES 11 ROBERT MORIN 20 SONYA NANDA JT MUNCH JAY NICHOLAS 3 LISA AULT RICHARD MURPHEY LIZ NYLUND JULIE BAILEY BORMAN ELISA 12 SAM NELSON 21 PATIENCE OLANITORI ADAM NORRIS MILICA PAVLOVIC 4 WILLIAM CAMPBELL COURTNEY PITTENGER ALLISON PERRIN GUIDO CASTAGNOLA CECE CHEN 13 VARNA RAMAN 22 PRAMOD PRASAD MORGAN SHATTUCK DARPITA PUROHIT 5 JAMES CHEUNG STEPH SHAW FENG QIAN BIRCE CIRAVOGLU EVAN COHEN 14 XIN (TONY) SHU 23 DIVYA RAJ ALEXANDER APARNA RAMAKRISHNAN 6 ELIZABETH COLONNA VON FALENHAUSEN ISOBEL ROSENTHAL CHRISTIAN DUNNE PHILONG DUONG 24 MEREDITH SHIELDS 2018 RESUMES JASON ZE SU 7 LEV ELDEMIR KEITH TABIN PAWEL FEDEJKO 14 YAPRAK BARAN 25 JEFFERSON TAYLOR EMILY GARVIN 15 JAMES BEALL ANGELA WANG DIANA BERKOVITS 8 RACHEL HAN MALLORY WEST CAROLYN HEISLER TRAVIS BOWDEN 26 ELLEN YANG QIAN HU 16 JESSICA CHO THORSON ZACH 9 SCOTT JOHNSON JOSEPH COSENTINO HILLARY KAPLAN KATIE DEAN VICTORIA LAI 17 ADAM ESCALANTE 10 SHREYAS LAKSHMINARAYAN MATTHEW FOXMAN JOSEPHINE LINTHORST ANDREW GOTTESDIENER JAMIE MEYERSON 18 STEPHANIE HU NAMWON JUNG JESSICA KIM 19 CHASE KNIGHT MOLLY MAGNUSON ALEX MARGOLIS HCIA AT COLUMBIA BUSINESS SCHOOL The Healthcare Industry Association (HCIA) is committed to expanding opportunities outside of the classroom for Columbia Business School students to learn about the many segments of the healthcare industry. Working in close collaboration with the Healthcare and Pharmaceutical Management Program, HCIA organizes a variety of activities throughout the year. It offers members the opportunity to increase their knowledge of the healthcare industry, expand their professional networks, learn about diverse career paths, and secure internships, full-time opportunities, and in-semester projects.
    [Show full text]
  • UHF's 2016 Annual Report
    UNITED HOSPITAL FUND Building a more effective health care system for every New Yorker ANNUAL REPORT 2016 OFFICERS AND DIRECTORS Officers Directors Improving Health Care for Every New Yorker J. Barclay Collins II Michelle A. Adams United Hospital Fund works to build a more effective health care Chairman Bettina Alonso system for every New Yorker. An independent, nonprofit Stephen Berger organization, we analyze public policy to inform decision-makers, James R. Tallon, Jr. Lori Evans Bernstein find common ground among diverse stakeholders, and develop and President Jo Ivey Boufford, MD support innovative programs that improve the quality, accessibility, Rev. John E. Carrington John C. Simons Dale C. Christensen, Jr. affordability, and experience of patient care. Frederick W. Telling, PhD J. Barclay Collins II Vice Chairmen Michael R. Golding, MD Eugene Keilin Sheila M. Abrams Cary A. Kravet United Hospital Fund Annual Report Treasurer Josh N. Kuriloff Fiscal Year 2015–2016 David Levy, MD Sheila M. Abrams Howard P. Milstein 2 From the President Sally J. Rogers Susana R. Morales, MD 4 Programs Senior Vice Presidents Robert C. Osborne John C. Simons 11 Grantmaking Deborah E. Halper Michael A. Stocker, MD, MPH 13 Financial Report Chad Shearer James R. Tallon, Jr. 16 Contributors Vice Presidents Frederick W. Telling, PhD Mary Beth C. Tully 20 Staff Amanda A. Williams Corporate Secretary Honorary Directors John K. Castle Timothy C. Forbes Barbara P. Gimbel Mary H. Schachne Allan Weissglass FROM THE CHAIRMAN “Working to build a more effective health care system for every New Yorker.” J. BARCLAY COLLINS II It would be hard to get more explicit or more concise than this CHAIRMAN UNITED HOSPITAL FUND reformulation of United Hospital Fund’s mission statement, which we undertook this year to better reflect UHF’s role in our rapidly transforming health care system.
    [Show full text]
  • Opioid Addiction
    Opioid Addiction Industry Outlook and Investment Opportunities 7 February 2021 1 Introduction Opioid addiction is a national epidemic with dangerous consequences, and without intervention, it will remain so for decades to come. The increase in opioid use, addiction and related deaths poses a critical challenge to society, as it affects all ages and demographic groups in the U.S. Private capital can play a significant role in combating the opioid crisis. Funding the development of new interventions, alternative drug therapies and innovative technologies can reduce widespread dependence and suffering. Within these distinct approaches lie many opportunities for investors to advance solutions capable of delivering affected individuals from despair and matching the desired risk-return profile. Highlights About 2 million people have been diagnosed with opioid use disorder (OUD) in the U.S. An additional 4 to 6 million people may also have the disease but have not been formally diagnosed. • According to the National Institute for Drug Abuse (NIDA), more than 130 Americans die every day from overdoses. • This translates into an annual cost of more than $78.5 billion in the U.S. across factors like systemic healthcare costs, lost productivity, treatment, and criminal justice activity. In one study, 35% of patients who were prescribed an opioid had a known risk factor for opioid use disorder (e.g. another substance abuse disorder). • Alerting healthcare providers about patients’ risk factors can allow doctors to make informed decisions when determining if patients should receive opioids or an alternative medication. • Significant progress can be achieved by improving how high-risk patients are handled and averting new opioid use disorder cases proactively.
    [Show full text]
  • CI Encourages You to Share This Content, However, in Doing So, You May Not Alter Its Contents
    Copyright © 2013 Connecticut Innovations All Rights Reserved CI encourages you to share this content, however, in doing so, you may not alter its contents. ctinnovations.com 1 FINDING THE RIGHT VC FOR YOUR COMPANY Tips from Successful Entrepreneurs Transforming a great idea into a successful company takes money. If you’re an entrepreneur, chances are that the first funds you’ll cobble together will come from you, your family, your friends and perhaps an angel investor. But at some point, taking your startup company to the next, crucial, level is likely to require an infusion of funds only a venture capital resource can provide. How do you go about finding the right VC for your particular company? Connecticut Innovations asked four experienced entrepreneurs with successful fundraising track records to offer their advice. Here are the pointers they offered: Start with Smart Targeting “Every firm has a sweet spot they’re looking for in terms of their favorite kinds of deals,” says Harry Penner Jr., executive chairman and co- founder of New Haven Pharmaceuticals. “You can save yourself from kissing a lot of frogs that turn out not to be princes if you do some homework before you start knocking on doors.” Do your research. Christopher McLeod, president and CEO of AxioMx Inc., suggests exploring which VCs have invested in other companies in your industry. Check out VCs’ portfolios online to see if they’ve invested in companies similar to yours. And make sure they’re actually working on deals in your time frame, says Bryant Guffey, CEO of ZetrOZ Inc.
    [Show full text]
  • Realim O Investm Ent© 2008
    REALIMO INVESTMENT vous permet d’entrer en relation avec les fonds français : 123 VENTURE - 17CAPITAL - 21 CENTRALE PARTNERS - 360° CAPITAL PARTNERS - 3I - 4D GLOBAL ENERGY ADVISORS - A PLUS FINANCE - ABENEX CAPITAL - ACCESS CAPITAL PARTNERS - ACE MANAGEMENT - ACG PRIVATE EQUITY - ACOFI GESTION - ACTEM PARTNERS - ACTIVA CAPITAL - ADC (ALLIANCE DEVELOPPEMENT CONSEIL) - ADVENT INTERNATIONAL - AGF PRIVATE EQUITY - AGREGATOR - AGRO INVEST SAS - ALLIANCE ENTREPRENDRE - ALOE PRIVATE EQUITY SAS - ALP CAPITAL - ALTER CAPITAL PARTNERS - ALTO INVEST - ALVEN CAPITAL PARTNERS - AMS INDUSTRIES - ANTIN INFRASTRUCTURE PARTNERS - APAX PARTNERS MIDMARKET - APAX PARTNERS SA - APOLLO MANAGEMENT INTERNATIONAL LLP - AQUASOURCA - ARCIS FINANCE - ARDENS ET ASSOCIES - ARGOS SODITIC FRANCE - ASSYA CAPITAL - ASTORG PARTNERS ATRIA CAPITAL PARTENAIRES - AURIGA PARTNERS - AURINVEST PARTENAIRES - AUXITEX - AVENIR ENTREPRISES - AVENIR FINANCE GESTION - AXA PRIVATE EQUITY - AZULIS CAPITAL - BAC PARTENAIRES GESTION - BANEXI VENTURES PARTNERS - BARCLAYS PRIVATE EQUITY FRANCE - BC PARTNERS - BIOAM GESTION - BLACKFIN CAPITAL PARTNERS BNP PARIBAS DEVELOPPEMENT - BNP PARIBAS PRIVATE EQUITY SAS - BRIDGEPOINT - BTP CAPITAL INVESTISSEMENT - BURELLE PARTICIPATIONS BUTLER CAPITAL PARTNERS - CAAM CI - CAP DECISIF MANAGEMENT - CAPZANINE - CARVEST - CATHAY CAPITAL PE - CAVIPAR - CDC CAPITAL INVESTISSEMENT - CDC ENTREPRISES - CDC INNOVATION - CEA VALORISATION - CENTRE CAPITAL DEVELOPPEMENT - CEREA GESTION - CHARTERHOUSE SERVICES FRANCE - CHEQUERS CAPITAL - CIC BANQUE DE VIZILLE -
    [Show full text]
  • REPORT 2015 Vol. 6
    REPORT 2015 vol. 6 Forward-thinking articles from our global network of innovation ecosystem experts KFR Staff KF Board of Directors Publisher Brian Dovey, Chairman Kauffman Fellows Press Domain Associates Executive Editor Tom Baruch Phil Wickham Formation 8 Managing Editor Jason Green Anna F.Doherty Emergence Capital Partners Associate Editor Karen Kerr Leslie F. Peters Agile Equities, LLC Production and Design Audrey MacLean Anna F. Doherty Stanford University Leslie F. Peters Susan Mason Printer Aligned Partners Almaden Press www.almadenpress.com Jenny Rooke Copyright Fidelity Biosciences © 2015 Kauffman Fellows. All rights reserved. Christian Weddell Under no circumstances shall any of the information provided herein be construed as investment advice of any kind. Copan About the Editor Phil Wickham Anna F. Doherty is an accomplished editor and writing Kauffman Fellows coach with a unique collaborative focus in her work. She has 20 years of editing experience on three continents in a variety of business industries. Through her firm, Together Editing & Design, she has offered a full suite of writing, design, and publishing services to Kauffman Fellows since 2009. Leslie F. Peters is the Lead Designer on the TE&D team. www.togetherediting.com www.kauffmanfellows.org Town & Country Village • 855 El Camino Real, Suite 12 • Palo Alto, CA 94301 Phone: 650-561-7450 • Fax: 650-561-7451 Venturing into the Industry: Lessons Learned from a VCpreneur Ahmad Takatkah Class 17 My life has been swinging between in Empretec,2 an international entrepreneurship and venture capital for more entrepreneurship training program than ten years now. In each cycle, I get closer that is managed by the United Nations and to my goal, even as I refine my goals further.
    [Show full text]
  • REPORT 2015 Vol. 6
    REPORT 2015 vol. 6 Forward-thinking articles from our global network of innovation ecosystem experts KFR Staff KF Board of Directors Publisher Brian Dovey, Chairman Kauffman Fellows Press Domain Associates Executive Editor Tom Baruch Phil Wickham Formation 8 Managing Editor Jason Green Anna F.Doherty Emergence Capital Partners Associate Editor Karen Kerr Leslie F. Peters Agile Equities, LLC Production and Design Audrey MacLean Anna F. Doherty Stanford University Leslie F. Peters Susan Mason Printer Aligned Partners Almaden Press www.almadenpress.com Jenny Rooke Copyright Fidelity Biosciences © 2015 Kauffman Fellows. All rights reserved. Christian Weddell Under no circumstances shall any of the information provided herein be construed as investment advice of any kind. Copan About the Editor Phil Wickham Anna F. Doherty is an accomplished editor and writing Kauffman Fellows coach with a unique collaborative focus in her work. She has 20 years of editing experience on three continents in a variety of business industries. Through her firm, Together Editing & Design, she has offered a full suite of writing, design, and publishing services to Kauffman Fellows since 2009. Leslie F. Peters is the Lead Designer on the TE&D team. www.togetherediting.com www.kauffmanfellows.org Town & Country Village • 855 El Camino Real, Suite 12 • Palo Alto, CA 94301 Phone: 650-561-7450 • Fax: 650-561-7451 A Hybrid Venture Capital Model for the Middle East Tarek Sadi Class 17 Youth unemployment in MENA, 1. Ten active family offices in the Middle East. 2. Five entrepreneurs who have raised capital in according to the Skoll Foundation, the region and beyond. is around 26% and among certain 3.
    [Show full text]
  • 3 Rivers Venture Fair Invite
    JOIN US FOR ONE OF THE COUNTRY’S FOREMOST TECHNOLOGY INVESTMENT SHOWCASES A catalyst for over $400 million in investment capital since 2002 Featuring Keynote Speaker Josh Linkner Founder, Chairman & Former CEO of ePrize CEO & Managing Partner of Detroit Venture Partners Best-Selling Author April 10 & 11, 2013 PNC Park | Pittsburgh, PA Proudly Presented by the Pittsburgh Venture Capital Association in partnership with leading organizations throughout the Midwest, Mid-Atlantic and Northeast Regions ABOUT THE 3 Rivers Venture Fair Since its debut in 2002, the 3 Rivers Venture Fair (3RVF) has become a recognized proving ground for promising technology pioneers, helping featured innovators raise more than $400 million in capital. Please join more than 600 attendees as they discover groundbreaking investment opportunities and explore over 40 remarkable advancements in life sciences, energy, communications, manufacturing, media and more. In addition to investor selected opportunities, the 3RVF also features networking, exhibits, a university technology showcase luncheon and awards, and investment-related panel discussions. WHAT’S NEW IN 2013? Two Concurrent Presentation Tracks More Companies. More Opportunities! . Choice of Two Breakfast Panels for Both Early & Later Stage Ventures Early Stage Sources of Capital: A look at economic development opportunities, crowdfunding & angel investors Funding Opportunities & Exits for Later Stage Companies: Exploring corporate M&A, business development, private equity & partnerships WHO Schedule SHOULD (subject to change) ATTEND WEDNESDAY, APRIL 10th 1:00 to 7:30 pm VENTURE Registration & Exhibits CAPITALISTS . 1:00 to 5:00 pm PRIVATE INVESTORS “Shark Tank” University . Technology Showcase & Luncheon LENDERS . 5:00 to 7:30 pm INVESTMENT Opening Cocktail Reception BANKERS & BROKERS .
    [Show full text]
  • Meet the Busiest Developer in the City
    20100405-NEWS--0001-NAT-CCI-CN_-- 4/2/2010 8:31 PM Page 1 INSIDE Financial reform’s TOP STORIES delicate task —Kathryn Bra manufacturer Wylde of the Maidenform needs Partnership for New no extra padding ® York City PAGE 2 Page 11 redux Macy’s parade VOL. XXVI, NO. 14 WWW.CRAINSNEWYORK.COM APRIL 5-11, 2010 PRICE: $3.00 route: It’s still up in Meet the the air busiest PAGE 2 Restaurants offer developer job security? Who knew? in the city PAGE 3 Web sites ramp up Gary Barnett has little fight for women debt, pots of cash and PAGE 3 a fair share of secrets Two dance troupes BY THERESA AGOVINO learn a new step: visitors can tour Gary Barnett’s real merging companies estate empire without ever leaving his PAGE 4 midtown office. A model of his nearly completed condo, 535 West End Avenue, sits just inside the door. Across the room is a mock-up of a hefty slice of the Upper BUSINESS LIVES West Side that includes the two towers he’s already built there, the two under construction and the five he hopes to start in the future.Nearby are models of the hotel/condo he’s putting up on West 57th Street and the 34-story tow- er going up in the diamond district. At a time when the credit crunch and recession have pushed many expe- rienced developers to the sidelines and inexperienced ones to the poorhouse, the ability of Extell Development Co.’s GOTHAM GIGS See BUSIEST on Page 21 Spring in bloom at the makeup counter P.
    [Show full text]